|
🌊 DIANA Biotechnologies, an EU-based biotech startup, is making waves in the industry with its groundbreaking PCR technology and innovative research.
🧑🔬 The founders of DIANA Biotechnologies, Václav Navrátil and Martin Dienstbier with their team, established a highly diversified biotech based on strong R&D in 3 business segments: PCR diagnostics, monoclonal antibodies and drug discovery services. Their goal is to become a global player in the field of molecular PCR diagnostics by investing in cutting-edge research in novel PCR technologies, and expanding their product portfolio for in-vitro diagnostics and life science . Here's what you need to know about our exciting company:
· Rapid Growth: Since 2020, DIANA Biotechnologies has experienced explosive growth, increasing by 335 % and recording record-high sales of almost 38,7 mil. EUR in 2021.
· Cutting-Edge Research: patented composition for ultra-sensitive direct PCR, PCR tests from saliva, advanced multiplex designs, unique proprietary enzymes for PCR applications, own oligonucleotide synthesis, proprietary pipeline for high-affinity monoclonal antibodies, DIANA technology for high-throughput screening and selectivity profiling in drug discovery and more.
· Revolutionary Products: DIANA Biotechnologies provided over 6 million PCR tests for respiratory viruses to help the Czech Republic combat the COVID-19 pandemic.
📈 DIANA Biotechnologies has been recognized for its rapid growth and innovation, being awarded as the fastest growing startup in the CEE region by Deloitte Fast 50. Join their community and stay up-to-date with the latest news in cutting-edge research and revolutionary PCR testing.
https://lnkd.in/dXRi4rF
#DIANABiotechnologies #PCRtesting #medicalstartup #moleculardiagnostics #pharmaceuticalresearch #globalexpansion #innovation #revolutionarytechnologies #multiplextest
|